{"log_id": 283357541809147982, "direction": 0, "words_result_num": 50, "words_result": [{"probability": {"variance": 9e-06, "average": 0.998681, "min": 0.989645}, "location": {"width": 209, "top": 177, "height": 26, "left": 158}, "words": "对药物过量的解救治疗"}, {"probability": {"variance": 4e-06, "average": 0.998703, "min": 0.990373}, "location": {"width": 786, "top": 198, "height": 41, "left": 159}, "words": "首先应保证呼吸道通畅,应建立一个专门的通气导管并提供辅助的或可控制的呼吸设施"}, {"probability": {"variance": 0.000404, "average": 0.995598, "min": 0.862853}, "location": {"width": 903, "top": 230, "height": 40, "left": 159}, "words": "在出现服药大量过量的情况下,如果患者出现昏迷或呼吸抑制,应静脉注射纳洛酮(成人剂量为0.4"}, {"probability": {"variance": 0.000687, "average": 0.992216, "min": 0.824981}, "location": {"width": 946, "top": 260, "height": 47, "left": 121}, "words": "至2mg,儿童剂量为每公斤体重0.01mg)。如仍没有反应,2分钟的时间间隔后重复给药。如果需要继续"}, {"probability": {"variance": 0, "average": 0.753421, "min": 0.753421}, "location": {"width": 56, "top": 192, "height": 135, "left": 1121}, "words": "陌"}, {"probability": {"variance": 0.004589, "average": 0.976386, "min": 0.658437}, "location": {"width": 942, "top": 293, "height": 41, "left": 120}, "words": "重复给药,可以静脉输注纳洛酮,初始剂量为60%初始给药量/小时。液体的制备是将10mg纳络酮溶于50ml"}, {"probability": {"variance": 5.1e-05, "average": 0.997226, "min": 0.954318}, "location": {"width": 941, "top": 322, "height": 46, "left": 120}, "words": "葡萄糖溶液中,制成200mg/ml的溶液,使用静脉输液泵进行输注(根据患者的临床反应调节用药剂量)"}, {"probability": {"variance": 2.7e-05, "average": 0.996127, "min": 0.978564}, "location": {"width": 412, "top": 365, "height": 30, "left": 121}, "words": "输液时同样需对患者的临床体征进行定期检查"}, {"probability": {"variance": 3.6e-05, "average": 0.997488, "min": 0.960915}, "location": {"width": 906, "top": 386, "height": 42, "left": 159}, "words": "如果静脉输液不适用于患者,可以进行肌肉注射。由于纳洛酮作用持续的时间相对较短,必须严密观"}, {"probability": {"variance": 0.002858, "average": 0.983977, "min": 0.728789}, "location": {"width": 944, "top": 419, "height": 40, "left": 120}, "words": "察,直到患者自主呼吸重新建立。纳络酮是一种竞争性桔抗剂;对于中毒严重的患者可能需要较大的剂量"}, {"probability": {"variance": 0.001689, "average": 0.970942, "min": 0.912826}, "location": {"width": 57, "top": 468, "height": 20, "left": 139}, "words": " 4mg)."}, {"probability": {"variance": 0.000147, "average": 0.99627, "min": 0.949598}, "location": {"width": 390, "top": 480, "height": 38, "left": 159}, "words": "如果中毒情况不太严重,可以先静脉"}, {"probability": {"variance": 0.008547, "average": 0.877181, "min": 0.784731}, "location": {"width": 108, "top": 457, "height": 49, "left": 541}, "words": "分销"}, {"probability": {"variance": 0.019354, "average": 0.947206, "min": 0.497046}, "location": {"width": 347, "top": 484, "height": 29, "left": 678}, "words": "类后如有必要,再每2分钟给药0.1mg"}, {"probability": {"variance": 0.001671, "average": 0.982622, "min": 0.863794}, "location": {"width": 533, "top": 510, "height": 56, "left": 161}, "words": "最后一次给予纳洛酮后,患者必须维6小时"}, {"probability": {"variance": 0.022682, "average": 0.945199, "min": 0.404569}, "location": {"width": 896, "top": 544, "height": 39, "left": 160}, "words": "服用羟考酮过量后,在临床上没有出显的呼抑制的循环抑制的情况下,不应使用纳络酮"}, {"probability": {"variance": 0.020947, "average": 0.949629, "min": 0.353425}, "location": {"width": 944, "top": 576, "height": 38, "left": 121}, "words": "对已知或怀疑其对吗啡产生身体依赖的人应重给药。在这种情下,阿片类药物作用的突然的和完全的"}, {"probability": {"variance": 6.4e-05, "average": 0.99739, "min": 0.968705}, "location": {"width": 291, "top": 616, "height": 28, "left": 121}, "words": "逆转可能加速出现急性戒断症状"}, {"probability": {"variance": 0, "average": 0.84268, "min": 0.84268}, "location": {"width": 37, "top": 618, "height": 35, "left": 999}, "words": "少"}, {"probability": {"variance": 0, "average": 0.999302, "min": 0.998699}, "location": {"width": 107, "top": 680, "height": 27, "left": 128}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.999854, "min": 0.999683}, "location": {"width": 86, "top": 712, "height": 24, "left": 121}, "words": "药理作用"}, {"probability": {"variance": 1.1e-05, "average": 0.998488, "min": 0.982626}, "location": {"width": 901, "top": 729, "height": 42, "left": 161}, "words": "盐酸羟考酮是一种阿片类镇痛药,为纯阿片受体激动剂,其主要治疗作用为镇痛。阿片类激动剂的药"}, {"probability": {"variance": 6.9e-05, "average": 0.997569, "min": 0.948014}, "location": {"width": 936, "top": 760, "height": 43, "left": 121}, "words": "理作用包括抗焦虑、欣快感、呼吸抑制、便秘、镇咳及镇痛。纯μ受体激动剂随剂量增加镇痛作用增强"}, {"probability": {"variance": 0.001168, "average": 0.992815, "min": 0.768836}, "location": {"width": 944, "top": 793, "height": 40, "left": 124}, "words": "与所有纯阿片受体激动型镇痛药一样,羟考酮没有确定的最大给药剂量;镇痛作用的最高限度只能通过副"}, {"probability": {"variance": 1e-06, "average": 0.999197, "min": 0.996029}, "location": {"width": 523, "top": 829, "height": 35, "left": 122}, "words": "作用来确定,较为严重的副作用可能包括嗜睡、呼吸抑制。"}, {"probability": {"variance": 6e-05, "average": 0.998443, "min": 0.947736}, "location": {"width": 903, "top": 852, "height": 42, "left": 163}, "words": "羟考酮镇痛作用的确切机制尚不清楚。在脑与脊髓中发现了一些具有类阿片作用内源性物质的特异性"}, {"probability": {"variance": 0, "average": 0.999592, "min": 0.998401}, "location": {"width": 496, "top": 887, "height": 33, "left": 124}, "words": "中枢神经系统阿片受体,可能与羟考酮的镇痛作用有关"}, {"probability": {"variance": 1e-06, "average": 0.99936, "min": 0.997956}, "location": {"width": 87, "top": 918, "height": 26, "left": 122}, "words": "毒理研究"}, {"probability": {"variance": 0, "average": 0.999795, "min": 0.999336}, "location": {"width": 85, "top": 949, "height": 23, "left": 123}, "words": "遗传毒性"}, {"probability": {"variance": 4.5e-05, "average": 0.997251, "min": 0.963256}, "location": {"width": 903, "top": 960, "height": 42, "left": 162}, "words": "羟考酮Ames试验、小鼠体内微核试验结果均为阴性。人淋巴细胞染色体畸变试验中,在无代谢活化"}, {"probability": {"variance": 0.005109, "average": 0.970418, "min": 0.656562}, "location": {"width": 946, "top": 989, "height": 43, "left": 122}, "words": "时剂量达1500μg/ml时、有代谢活化剂量达5000ug/ml处理48小时时结果为阴性,但在有代谢活化剂量≥"}, {"probability": {"variance": 0.007554, "average": 0.969206, "min": 0.546489}, "location": {"width": 939, "top": 1017, "height": 43, "left": 127}, "words": "250μg/ml处理24小时时结果为阳性;在小鼠淋巴瘤试验中,在有代谢活化剂量≥50μg/ml、无代谢活化"}, {"probability": {"variance": 0.001457, "average": 0.98474, "min": 0.872447}, "location": {"width": 266, "top": 1054, "height": 27, "left": 124}, "words": "剂量≥400μg/ml时结果为阳性"}, {"probability": {"variance": 1e-06, "average": 0.998643, "min": 0.997868}, "location": {"width": 84, "top": 1085, "height": 23, "left": 124}, "words": "生殖毒性"}, {"probability": {"variance": 0.001509, "average": 0.991592, "min": 0.728018}, "location": {"width": 905, "top": 1098, "height": 39, "left": 163}, "words": "大鼠生育力试验中,大鼠每日灌胃给予一次盐酸羟考酮0.5、2、8mgkg,雄性大鼠于交配前28天给"}, {"probability": {"variance": 0.00043, "average": 0.995042, "min": 0.856264}, "location": {"width": 944, "top": 1124, "height": 41, "left": 124}, "words": "药至剖检时(交配后2至3周),雌性大鼠于交配前14天给药至妊娠第6天,对雄性或雌性大鼠生育力未"}, {"probability": {"variance": 0.000133, "average": 0.996491, "min": 0.919403}, "location": {"width": 945, "top": 1152, "height": 40, "left": 123}, "words": "见影响。大鼠与家兔经口给予羟考酮剂量分别达8mg/kg与125mg/kg(按mg/m2计算,分别相当于成人"}, {"probability": {"variance": 0.000136, "average": 0.996399, "min": 0.922785}, "location": {"width": 944, "top": 1177, "height": 43, "left": 124}, "words": "剂量160mg天的0.5倍与15倍),未见羟考酮所致的胎仔毒性。大鼠围产期毒性试验中未见对仔鼠的发育"}, {"probability": {"variance": 0.000134, "average": 0.99572, "min": 0.930621}, "location": {"width": 941, "top": 1205, "height": 41, "left": 124}, "words": "和生殖有长期影响,高剂量(6mg/kg,按mg/m2计算相当于成人剂量160mg天的0.4倍)组仔鼠在哺乳"}, {"probability": {"variance": 0.000168, "average": 0.995839, "min": 0.933742}, "location": {"width": 534, "top": 1238, "height": 34, "left": 124}, "words": "期间和离乳早期阶段可见体重降低,但这种体重降低可恢复"}, {"probability": {"variance": 0, "average": 0.999717, "min": 0.999475}, "location": {"width": 66, "top": 1276, "height": 23, "left": 123}, "words": "致癌性"}, {"probability": {"variance": 1e-06, "average": 0.999129, "min": 0.997244}, "location": {"width": 352, "top": 1300, "height": 32, "left": 165}, "words": "未进行过羟考酮致癌性评估的动物试验"}, {"probability": {"variance": 1e-06, "average": 0.999308, "min": 0.997705}, "location": {"width": 132, "top": 1367, "height": 26, "left": 132}, "words": "【药代动力学】"}, {"probability": {"variance": 2.2e-05, "average": 0.997785, "min": 0.973495}, "location": {"width": 904, "top": 1383, "height": 43, "left": 165}, "words": "分别将羟考酮注射液经皮下注射或静脉注射给予健康受试者,不论是一次注射或是在8小时内连续灌"}, {"probability": {"variance": 3.8e-05, "average": 0.997137, "min": 0.973231}, "location": {"width": 577, "top": 1420, "height": 36, "left": 124}, "words": "注相同的剂量,皮下注射与静脉注射两种给药途径呈生物等效性"}, {"probability": {"variance": 0.000109, "average": 0.997037, "min": 0.931323}, "location": {"width": 909, "top": 1444, "height": 43, "left": 162}, "words": "吸收后,羟考酮分布至全身。约45%与血浆蛋白结合。经肝脏代谢为去甲羟考酮、羟吗啡酮及其与葡"}, {"probability": {"variance": 2.8e-05, "average": 0.997063, "min": 0.978877}, "location": {"width": 432, "top": 1483, "height": 36, "left": 128}, "words": "萄醛酸的结合型。代谢物的镇痛作用无临床意义"}, {"probability": {"variance": 3e-06, "average": 0.99916, "min": 0.991608}, "location": {"width": 394, "top": 1515, "height": 31, "left": 165}, "words": "活性药物和代谢物可以通过尿液和粪便排泄"}, {"probability": {"variance": 6.3e-05, "average": 0.996992, "min": 0.957222}, "location": {"width": 602, "top": 1539, "height": 40, "left": 166}, "words": "羟考酮的血浆浓度受年龄影响较小,老年患者与年轻人相比高15%"}, {"probability": {"variance": 7.3e-05, "average": 0.997228, "min": 0.948922}, "location": {"width": 745, "top": 1569, "height": 40, "left": 165}, "words": "对于女性受试者,总体来说,在经体重调整的基础上,血药浓度最多比男性高25%"}], "language": 3}